Gilead, IPA, Natco & The Bells of Harmony
The post examines the collaboration between Gilead, IPA, and Natco Pharma regarding the sofosbuvir patent in India. It analyses how voluntary licensing and innovative policies are improving access…
Gaurav Mishra
189 articles
Gaurav Mishra is an intellectual property attorney, coffee entrepreneur, and passionate educator. As an Associate Partner at BananaIP Counsels, he specializes in patents, trademarks, copyrights, and designs, working with global tech and innovation-driven clients.
Ericsson has a (i)Ball at the Court
The Delhi High Court granted an interim injunction to Ericsson against iBall in a significant patent infringement dispute involving standard essential patents for mobile technologies. The court found…
Pfizer falls prey to Section 3(d)
This post analyses the Indian Patent Office’s rejection of Pfizer’s Tofacitinib patent under Section 3(d). The decision addresses issues of novelty, inventive step, and the requirement for evidence…
When Patents and Planes Travel Faster than Sound
This post examines the Airbus patent for an ultra-rapid air vehicle, offering commercial supersonic travel at unprecedented speeds. It analyses the key technical innovations and potential applications outlined…
India Claims Patents
India’s Traditional Knowledge Digital Library has become a crucial tool in preventing foreign patent claims on traditional medical knowledge and practices. Through CSIR-TKDL, India has successfully protected its…
The greatest ‘Intellectual Property’ of Our Nation
Dr APJ Abdul Kalam’s life and work exemplify the highest ideals of innovation for national good. His approach to intellectual property and technology continues to inspire generations in…
Fumbling Flights and Patent Rights!
This post examines the legal and practical aspects of a new airline seat patent filed by Zodiac Seats France. It discusses the implications for passenger comfort, safety regulations,…
Ready to Pa(y)tent in France?
The INPI has revised its patent procedure fees in France, increasing the overall cost of obtaining and maintaining patents from July 2015. This post analyses the legal and…
Patent Infringement Claim on Cancer Treatment Drug
The UK Court of Appeal ruled that Actavis’s alternative salt forms of pemetrexed would indirectly infringe Eli Lilly’s cancer drug patent. The decision provides insights into patent claim…